JenaValve Technology Revenue and Competitors
Estimated Revenue & Valuation
- JenaValve Technology's estimated annual revenue is currently $57.1M per year.
- JenaValve Technology's estimated revenue per employee is $339,896
- JenaValve Technology's total funding is $502M.
Employee Data
- JenaValve Technology has 168 Employees.
- JenaValve Technology grew their employee count by 2% last year.
JenaValve Technology's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | VP Global Operations | Reveal Email/Phone |
4 | VP Operations | Reveal Email/Phone |
5 | VP, Global Clinical Operations | Reveal Email/Phone |
6 | VP Regulatory Affairs and Quality | Reveal Email/Phone |
7 | VP, Global Clinical Affairs | Reveal Email/Phone |
8 | Director Regulatory Affairs | Reveal Email/Phone |
9 | Chief Medical Officer | Reveal Email/Phone |
10 | Director, Strategy and Field Operations | Reveal Email/Phone |
JenaValve Technology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $20.3M | 79 | 20% | N/A | N/A |
#2 | $8.5M | 31 | 11% | N/A | N/A |
#3 | $4.5M | 13 | -13% | N/A | N/A |
#4 | $8M | 25 | -4% | N/A | N/A |
#5 | $5.3M | 16 | -6% | N/A | N/A |
#6 | $54.2M | 163 | -8% | N/A | N/A |
#7 | $12M | 55 | -17% | $63.2M | N/A |
#8 | $10M | 30 | -9% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 43 | -7% | N/A | N/A |
What Is JenaValve Technology?
JenaValve Technology, Inc., with locations in Irvine, Calif., Leeds, U.K. and Munich, Germany, develops and manufactures transcatheter aortic valve replacement (TAVR) systems to treat patients suffering from aortic valve disease. The Company is in clinical development of its next-generation transfemoral TAVR system in both the U.S. and CE mark countries for treating patients with aortic stenosis and/or aortic regurgitation. In addition to Bain Capital Life Sciences, JenaValve is backed by European and Asian investors, including Andera Partners (formerly Edmond de Rothschild Investment Partners), Gimv (Euronext: GIMB), Legend Capital, NeoMed Management, RMM, Valiance Life Sciences and VI Partners. Additional information is available at www.jenavalve.com.
keywords:N/A
$502M
Total Funding
168
Number of Employees
$57.1M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
JenaValve Technology News
... including new technologies, industry drivers, challenges, ... Inc., Edwards Lifesciences Corporation, JenaValve Technology GmbH.
... Boston Scientific, Edward Lifesciences, TTK HealthCare, JenaValve Technology, Medtronic, Neovasc, Sorin Group, Micro Interventional.
... Boston Scientific Corp., Colibri Heart Valve LLC, Edwards Lifesciences Corp., JenaValve Technology Inc., LivaNova Plc, Medtronic Plc,...
Irvine-based JenaValve Technology, which develops aortic valve replacements, said last week that it has raised $50M in a financing round. The funding was led by Bain Capital Life Sciences, and also included existing investors Andera Partners, Gimv, Legend Capital, NeoMed Management, RMM, Valianc ...
Heart valve maker JenaValve Technology has raised $50 million in new venture capital funding, not long after receiving a breakthrough device designation from the FDA for its transcatheter aortic valve replacement (TAVR) system. Sponsored by Agilent Technologies How would you like to win free b ...
Other Companies in Irvine
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $73.7M | 168 | 11% | N/A |
#2 | $58.7M | 168 | -11% | N/A |
#3 | $30.1M | 168 | -8% | N/A |
#4 | $27.1M | 169 | 4% | N/A |
#5 | $39M | 169 | 36% | N/A |